ArticlePharmaceuticals (Basel, Switzerland)2021

Incident Type 2 Diabetes Risk of Selective Estrogen Receptor Modulators in Female Patients with Breast Cancer.

Yeo-Jin Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.